QUALCOMM Incorporated (QCOM) retreated with the stock falling -0.03% or $-0.02 to close at $65.63 on light trading volume of 6.07M compared its three months average trading volume of 8.86M. The San Diego California 92121 based company operating under the Communication Equipment industry has been trending up for the last 52 weeks, with the shares price now 47.55% up for the period and up by 0.66% so far this year. With price target of $73.5 and a 60.93% rebound from 52-week low, QUALCOMM Incorporated has plenty of upside potential, making it a hold with a view buy.
QUALCOMM Incorporated develops, designs, manufactures, and markets digital communications products and services in China, South Korea, Taiwan, the United States, and internationally. The company operates through three segments: Qualcomm CDMA Technologies (QCT); Qualcomm Technology Licensing (QTL); and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on code division multiple access (CDMA), orthogonal frequency division multiple access (OFDMA), and other technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses or provides rights to use portions of its intellectual property portfolio, which include various patent rights useful in the manufacture and sale of certain wireless products comprising products implementing CDMA2000, WCDMA, CDMA TDD, and/or LTE standards, as well as their derivatives. The QSI segment invests in early-stage companies in various industries, including digital media, e-commerce, healthcare, and wearable devices for supporting the design and introduction of new products and services for voice and data communications. The company also develops and offers products for implementation of small cells; mobile health products and services; software products, and content and push-to-talk enablement services to wireless operators; and development, and other services and related products to the United States government agencies and their contractors. In addition, it licenses chipset technology and products for data centers. QUALCOMM Incorporated was founded in 1985 and is headquartered in San Diego, California.
Illumina, Inc. (ILMN) gained $23.5 to close the day at a new closing price of $165.04, a 16.6% increase in value from its previous closing price that moved the stock 38.26% above its 52 week low of $119.37. A total of 6.03M shares exchanged hands during the day compared with its three month average trading volume of 1.6M. The stock, currently situated -11.69% below its 52 week high. The stock is up by 33.66% in the past one month and down by -10.72% over the past three months. With a one year target estimate of $140.41 and RSI of 84.4, the stock still has upside potential, making it a sell for now.
Illumina, Inc. provides sequencing and array-based solutions for genetic analysis. The company’s sequencing by synthesis technology provides researchers with various applications and the ability to sequence mammalian genomes. It also offers arrays for a range of deoxyribonucleic acid and RNA analysis applications, including single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis, as well as allow for the detection of known genetic markers on a single array. In addition, the company provides various library preparation and sequencing kits to simplify workflows and accelerate analysis; and genome sequencing, genotyping, and non-invasive prenatal testing services. It serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as through life-science distributors. It has a collaboration agreement With MolecularMD Corporation for drug-diagnostic co-development with biopharma drug programs. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.
Hanesbrands Inc. (HBI) shares were up in last trading by 0.95% to $22.43. It experienced lighter than average volume on day. The stock increased in value by almost 1.4% over the past week and fell -2.01% in the past month. It is currently trading -3.93% below its 50 day moving average and -12.51% below its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -27.25% decrease in value from its one year high of $31.36. The RSI indicator value of 49.27, lead us to believe that it is a hold for now.
Hanesbrands Inc., a consumer goods company, designs, manufactures, sources, and sells various basic apparels for men, women, and children in the United States. The company operates through four segments: Innerwear, Activewear, Direct to Consumer, and International. It sells bras, panties, shapewears, hosiery, men’s underwear, children’s underwear, and socks; and other activewear, such as T-shirts, fleece, sport shirts, performance T-shirts and shorts, sports bras, and thermals, as well as licensed logo apparel in collegiate bookstores and other channels. The company licenses its Champion name for footwear and sports accessories. It provides its products primarily under the Maidenform, Bali, Playtex, Hanes, JMS/Just My Size, Lilyette, Wonderbra, Donna Karan, DKNY, Champion, Polo Ralph Lauren, L’eggs, Hanes Beefy-T, Gear for Sports, Duofold, DIM, Nur Die/Nur Der, Lovable, Shock Absorber, Abanderado, Zorba, Rinbros, Kendall, Sol y Oro, Fila, Bellinda, Edoo, and Track N Field brand names. The company markets its products through retailers, wholesalers, and third party embellishers, as well as directly to consumers. As of January 2, 2016, it operated 252 outlet stores in the United States; and Websites under the Hanes, One Hanes Place, JMS/Just My Size, Champion, and Maidenform names. The company also sells its products in Europe, Asia, Latin America, Canada, Australia, the Middle East, Africa, and the Caribbean. Hanesbrands Inc. was founded in 2005 and is headquartered in Winston-Salem, North Carolina.